223 related articles for article (PubMed ID: 29229993)
1. Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer.
Álvarez-Fernández M; Sanz-Flores M; Sanz-Castillo B; Salazar-Roa M; Partida D; Zapatero-Solana E; Ali HR; Manchado E; Lowe S; VanArsdale T; Shields D; Caldas C; Quintela-Fandino M; Malumbres M
Cell Death Differ; 2018 May; 25(5):828-840. PubMed ID: 29229993
[TBL] [Abstract][Full Text] [Related]
2. MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells.
Yoon YN; Choe MH; Jung KY; Hwang SG; Oh JS; Kim JS
BMC Cancer; 2018 Jul; 18(1):716. PubMed ID: 29976159
[TBL] [Abstract][Full Text] [Related]
3. MASTL: A novel therapeutic target for Cancer Malignancy.
Fatima I; Singh AB; Dhawan P
Cancer Med; 2020 Sep; 9(17):6322-6329. PubMed ID: 32692487
[TBL] [Abstract][Full Text] [Related]
4. MASTL overexpression promotes chromosome instability and metastasis in breast cancer.
Rogers S; McCloy RA; Parker BL; Gallego-Ortega D; Law AMK; Chin VT; Conway JRW; Fey D; Millar EKA; O'Toole S; Deng N; Swarbrick A; Chastain PD; Cesare AJ; Timpson P; Caldon CE; Croucher DR; James DE; Watkins DN; Burgess A
Oncogene; 2018 Aug; 37(33):4518-4533. PubMed ID: 29743597
[TBL] [Abstract][Full Text] [Related]
5. Loss of the Greatwall Kinase Weakens the Spindle Assembly Checkpoint.
Diril MK; Bisteau X; Kitagawa M; Caldez MJ; Wee S; Gunaratne J; Lee SH; Kaldis P
PLoS Genet; 2016 Sep; 12(9):e1006310. PubMed ID: 27631493
[TBL] [Abstract][Full Text] [Related]
6. Greatwall is essential to prevent mitotic collapse after nuclear envelope breakdown in mammals.
Álvarez-Fernández M; Sánchez-Martínez R; Sanz-Castillo B; Gan PP; Sanz-Flores M; Trakala M; Ruiz-Torres M; Lorca T; Castro A; Malumbres M
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17374-9. PubMed ID: 24101512
[TBL] [Abstract][Full Text] [Related]
7. PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cells.
Rogers S; Fey D; McCloy RA; Parker BL; Mitchell NJ; Payne RJ; Daly RJ; James DE; Caldon CE; Watkins DN; Croucher DR; Burgess A
J Cell Sci; 2016 Apr; 129(7):1340-54. PubMed ID: 26872783
[TBL] [Abstract][Full Text] [Related]
8. PP2A/B55 and Fcp1 regulate Greatwall and Ensa dephosphorylation during mitotic exit.
Hégarat N; Vesely C; Vinod PK; Ocasio C; Peter N; Gannon J; Oliver AW; Novák B; Hochegger H
PLoS Genet; 2014 Jan; 10(1):e1004004. PubMed ID: 24391510
[TBL] [Abstract][Full Text] [Related]
9. The MASTL/PP2A cell cycle kinase-phosphatase module restrains PI3K-Akt activity in an mTORC1-dependent manner.
Sanz-Castillo B; Hurtado B; Vara-Ciruelos D; El Bakkali A; Hermida D; Salvador-Barbero B; Martínez-Alonso D; González-Martínez J; Santiveri C; Campos-Olivas R; Ximénez-Embún P; Muñoz J; Álvarez-Fernández M; Malumbres M
EMBO J; 2023 Jan; 42(2):e110833. PubMed ID: 36354735
[TBL] [Abstract][Full Text] [Related]
10. Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression.
Della Monica R; Visconti R; Cervone N; Serpico AF; Grieco D
Elife; 2015 Dec; 4():. PubMed ID: 26653855
[TBL] [Abstract][Full Text] [Related]
11. AKT Regulates Mitotic Progression of Mammalian Cells by Phosphorylating MASTL, Leading to Protein Phosphatase 2A Inactivation.
Reshi I; Nisa MU; Farooq U; Gillani SQ; Bhat SA; Sarwar Z; Nabi N; Fazili KM; Andrabi S
Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123010
[TBL] [Abstract][Full Text] [Related]
12. Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma.
Dahlhaus M; Burkovski A; Hertwig F; Mussel C; Volland R; Fischer M; Debatin KM; Kestler HA; Beltinger C
Cancer Lett; 2016 Feb; 371(1):79-89. PubMed ID: 26616283
[TBL] [Abstract][Full Text] [Related]
13. Greatwall dephosphorylation and inactivation upon mitotic exit is triggered by PP1.
Ma S; Vigneron S; Robert P; Strub JM; Cianferani S; Castro A; Lorca T
J Cell Sci; 2016 Apr; 129(7):1329-39. PubMed ID: 26906418
[TBL] [Abstract][Full Text] [Related]
14. Protein phosphatase 1 is essential for Greatwall inactivation at mitotic exit.
Heim A; Konietzny A; Mayer TU
EMBO Rep; 2015 Nov; 16(11):1501-10. PubMed ID: 26396231
[TBL] [Abstract][Full Text] [Related]
15. The Greatwall kinase safeguards the genome integrity by affecting the kinome activity in mitosis.
Bisteau X; Lee J; Srinivas V; Lee JHS; Niska-Blakie J; Tan G; Yap SYX; Hom KW; Wong CK; Chae J; Wang LC; Kim J; Rancati G; Sobota RM; Tan CSH; Kaldis P
Oncogene; 2020 Oct; 39(44):6816-6840. PubMed ID: 32978522
[TBL] [Abstract][Full Text] [Related]
16. E2F8 confers cisplatin resistance to ER+ breast cancer cells via transcriptionally activating MASTL.
Tian J; Lin Y; Yu J
Biomed Pharmacother; 2017 Aug; 92():919-926. PubMed ID: 28605876
[TBL] [Abstract][Full Text] [Related]
17. Greatwall-Endosulfine: A Molecular Switch that Regulates PP2A/B55 Protein Phosphatase Activity in Dividing and Quiescent Cells.
García-Blanco N; Vázquez-Bolado A; Moreno S
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835586
[TBL] [Abstract][Full Text] [Related]
18. Greatwall kinase at a glance.
Castro A; Lorca T
J Cell Sci; 2018 Oct; 131(20):. PubMed ID: 30355803
[TBL] [Abstract][Full Text] [Related]
19. The MASTL-ENSA-PP2A/B55 axis modulates cisplatin resistance in oral squamous cell carcinoma.
Gouttia OG; Zhao J; Li Y; Zwiener MJ; Wang L; Oakley GG; Peng A
Front Cell Dev Biol; 2022; 10():904719. PubMed ID: 36247015
[TBL] [Abstract][Full Text] [Related]
20. Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphatase.
Manchado E; Guillamot M; de Cárcer G; Eguren M; Trickey M; García-Higuera I; Moreno S; Yamano H; Cañamero M; Malumbres M
Cancer Cell; 2010 Dec; 18(6):641-54. PubMed ID: 21156286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
